New research shows how RNA, a key molecule for life, may have formed on early Earth using simple chemistry and materials delivered by asteroid impacts, linking space science with the origins of life ...

A study of female U.S. service members found that getting a COVID-19 vaccine before or during pregnancy didn't raise the risk ...

In a new study, we and an international team scientists examined the behavior of marine viruses in a large band of ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

An astronaut in need of medical care is on the way back to Earth, NASA's first medical evacuation from space. The ailing ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

In addition to its Chinese R&D and manufacturing centers in Beijing and Suzhou, Ribo also set up a subsidiary, Ribocure AB, ...

Korro is a biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent diseases. Korro is generating a portfolio of ...

In late 2025, Arcturus Therapeutics Holdings Inc. filed an omnibus shelf registration of up to US$500 million, covering ...

Hiking through Bear Mountain State Park in New York, the Rutgers chemist saw plastic bottles scattered along the path and ...

The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...